These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3332140)
21. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells. Howell AL; Fogg-Leach M; Davis BH; Ball ED Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117 [TBL] [Abstract][Full Text] [Related]
22. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia. Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833 [TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation for leukemia. Stuart RK Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215 [TBL] [Abstract][Full Text] [Related]
25. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction. Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022 [TBL] [Abstract][Full Text] [Related]
26. [ICO-35 monoclonal antibodies to the antigen of acute lymphoblastic leukemia]. Baryshnikov AIu; Tupitsyn NN; Korotkova OV; Kadagidze ZG; Dostot E; Shmidt M; Boumsell L Eksp Onkol; 1989; 11(5):52-3. PubMed ID: 2529115 [TBL] [Abstract][Full Text] [Related]
27. Comparison of magnetic particles for immunomagnetic bone marrow purging using an acute lymphoblastic leukaemia model. Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR Transplant Proc; 1990 Oct; 22(5):2177-8. PubMed ID: 2219335 [No Abstract] [Full Text] [Related]
29. Sensitive detection of residual acute lymphoblastic leukemia cells for monitoring bone marrow purging. Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR Transplant Proc; 1990 Oct; 22(5):2175-6. PubMed ID: 2219334 [No Abstract] [Full Text] [Related]
30. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia. Jándula BM; Nomdedeu J; Marín P; Vivancos P Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397 [TBL] [Abstract][Full Text] [Related]
31. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells. Andreasen RB; Olsson L J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756 [TBL] [Abstract][Full Text] [Related]
32. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268 [TBL] [Abstract][Full Text] [Related]
34. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468 [TBL] [Abstract][Full Text] [Related]
35. Malignant leukemic cell separation by iron colloid immunomagnetic adsorption. Biéva CJ; Vander Brugghen FJ; Stryckmans PA Exp Hematol; 1989 Sep; 17(8):914-20. PubMed ID: 2670597 [TBL] [Abstract][Full Text] [Related]
36. Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia. Vervoordeldonk SF; van den Berg H; von dem Borne AE; van Leeuwen EF; Slaper-Cortenbach IC J Hematother; 1997 Oct; 6(5):495-500. PubMed ID: 9368186 [TBL] [Abstract][Full Text] [Related]
37. A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment. Wang MY; Fodstad O; Funderud S; Bengtsson M; Totterman T; Ludwig WD; Martin H; Kvalheim G Prog Clin Biol Res; 1994; 389():119-24. PubMed ID: 7700893 [No Abstract] [Full Text] [Related]
38. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. Civin CI; Strauss LC; Brovall C; Fackler MJ; Schwartz JF; Shaper JH J Immunol; 1984 Jul; 133(1):157-65. PubMed ID: 6586833 [TBL] [Abstract][Full Text] [Related]
39. Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings. Foa R; Meloni G; Tosti S; Novarino A; Fenu S; Guarini A; Cardona S; Gillio Tos A; Gavosto F; Mandelli F Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():98-102. PubMed ID: 2202476 [No Abstract] [Full Text] [Related]
40. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60). Aota F; Chang D; Hill NO; Khan A Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]